| 摘要 |
A novel biomaterial is disclosed having unique properties that make it useful in ocular drug delivery applications, where the drugs selected from the group consisting of a prostaglandin, a prostamide, a non-steroidal anti-inflammatory drug (NSAID), and a corticosteroid, and mixtures, derivatives, salts and esters thereof. |
| 申请人 |
ALLERGAN, INC.;UTECHT, RONALD, E.;KLOSTER, KAIA, L.;DOWNEY, THERESE, M.;HABERER, BARBARA, R.;YOUSO, PATRICK, D.;CHANG, JAMES, N. |
发明人 |
UTECHT, RONALD, E.;KLOSTER, KAIA, L.;DOWNEY, THERESE, M.;HABERER, BARBARA, R.;YOUSO, PATRICK, D.;CHANG, JAMES, N. |
